Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD.

about

Management of severe acute exacerbations of COPD: an updated narrative review The role of CAT in evaluating the response to treatment of patients with AECOPD

P2860

Q57298307-8659BB46-E9BA-4D45-A6E3-C94E054FCA89 Q58751086-27276E39-579B-4FB1-90DB-8DE5E23B12D9

P2860

Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD.

Item

http://www.wikidata.org/entity/Q54998966

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD.

@en

Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD.

@nl

type

Item

label

Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD.

@en

Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD.

@nl

prefLabel

Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD.

@en

Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD.

@nl

P1476

Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD

@en

P2093

Achim Mueller

http://www.w3.org/2001/XMLSchema#string

Antonio R Anzueto

http://www.w3.org/2001/XMLSchema#string

Daniel Dusser

http://www.w3.org/2001/XMLSchema#string

Norbert Metzdorf

http://www.w3.org/2001/XMLSchema#string

Peter Ma Calverley

http://www.w3.org/2001/XMLSchema#string

P2860

Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis

Inhaled corticosteroids for stable chronic obstructive pulmonary disease

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.

Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group.

Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial.

Tiotropium Respimat inhaler and the risk of death in COPD.

Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results.

Impact of Prolonged Exacerbation Recovery in Chronic Obstructive Pulmonary Disease.

The Tiotropium Safety and Performance in Respimat Trial (TIOSPIR), a large scale, randomized, controlled, parallel-group trial-design and rationale

Assisted ventilation in COPD - association between previous hospitalizations and mortality.

P304

1297-1308

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/COPD.S153631

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Robert A. Wise

P577

2018-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29719385

http://www.w3.org/2001/XMLSchema#string

P932

5922419

http://www.w3.org/2001/XMLSchema#string

Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD.

about

P2860

P2860

Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P932